Related Experiment Videos
Serum interleukin-6 in schizophrenic patients.
1Department of Neuro-psychiatry, Keio University, School of Medicine, Tokyo, Japan.
Life Sciences
|January 1, 1991
Summary
Schizophrenia patients showed significantly different serum interleukin-6 (IL-6) levels compared to healthy individuals. This suggests a potential link between schizophrenia, immune responses, and autoimmune processes or viral reactivation.
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Background:
- Schizophrenia is a complex mental disorder with suspected links to immune system dysfunction.
- Elevated levels of interleukin-6 (IL-6) are observed in various autoimmune conditions.
Purpose of the Study:
- To investigate serum interleukin-6 (IL-6) levels in patients with schizophrenia in remission.
- To compare IL-6 levels between schizophrenic patients and healthy controls.
Main Methods:
- Enzyme-linked immuno-sorbent assay (ELISA) was used to measure serum IL-6.
- Study included 90 schizophrenic patients in remission and 90 normal controls.
Main Results:
- A statistically significant difference in serum IL-6 levels was found between the schizophrenic and control groups (F = 10.9, P < .002).
- Kolmogorov-Smirnov test also indicated a significant difference in distribution (chi-square = 45.0, P < .001).
- Eight patients exhibited aberrantly high serum IL-6 levels.
Conclusions:
- Findings suggest a potential association between schizophrenia and immune response.
- This immune link may involve autoimmune mechanisms or viral reactivation in schizophrenia.